Shilpa Medicare has introduced Capecitabine 1000 MG dispersible tablet for the first time in the world, with novel technology of faster dispersion within 90 seconds. The company has launched the product in the Indian market on December 16, 2022 and is further looking to introduce Capebel 1 gm DT in various international markets through its … Read more
Shilpa Medicare is currently trading at Rs. 418.35, up by 20.25 points or 5.09% from its previous closing of Rs. 398.10 on the BSE. The scrip opened at Rs. 406.00 and has touched a high and low of Rs. 424.40 and Rs. 405.40 respectively. So far 41884 shares were traded on the counter. The BSE … Read more
Shilpa Medicare’s Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to use formulation is approved by European Authorities, through its agreed partners in Europe. The product will be manufactured, for EU commercialization at its own EU GMP compliant, injectable manufacturing facility situated in Telangana state. Shilpa has developed Pemetrexed formulation … Read more
Shilpa Medicare is currently trading at Rs. 531.00, up by 14.75 points or 4.21% from its previous closing of Rs. 516.25 on the BSE. The scrip opened at Rs. 519.00 and has touched a high and low of Rs. 543.10 and Rs. 510.00 respectively. So far 54211 shares were traded on the counter. The BSE … Read more
Shilpa Medicare is currently trading at Rs. 501.30, up by 45.95 points or 10.09% from its previous closing of Rs. 455.35 on the BSE. The scrip opened at Rs. 462.00 and has touched a high and low of Rs. 516.95 and Rs. 462.00 respectively. So far 143028 shares were traded on the counter. The BSE … Read more